AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Por Zielinski, Christoph C, Pinto, Carmine
Publicado no ESMO Open (2016)

ESMO Open—Cancer Horizons and the future of oncology

Por Zielinski, Christoph C
Publicado no ESMO Open (2016)

CSCO joins ESMO Open—Cancer Horizons

Por Zielinski, Christoph C, Wu, Yi-Long
Publicado no ESMO Open (2016)

Highlights for ESMO 40: celebration review for lifetime achievement awards

Por Saijo, Nagahiro
Publicado no ESMO Open (2016)

Drug development: successes, problems and pitfalls—the industry perspective

Por Wein, Wolfgang
Publicado no ESMO Open (2016)

Cancer and the arts: Johannes Brahms and the problem of pancreatic carcinoma

Por Wagner, Wolfgang
Publicado no ESMO Open (2016)

In the literature: March 2016

Por Cervantes, A
Publicado no ESMO Open (2016)

In the literature: May 2016

Por Cervantes, A
Publicado no ESMO Open (2016)

ESMO and WHO: 14 years of working in partnership on cancer control

Por Ullrich, Andreas, Ciardiello, Fortunato, Bricalli, Gracemarie, Cherny, Nathan I, Eniu, Alexandru
Publicado no ESMO Open (2016)

Correction

Publicado no ESMO Open (2016)

In the literature: October 2016

Por Cervantes, Andres
Publicado no ESMO Open (2016)

Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?

Por Addeo, A, Fusco, V, Braybrooke, JP
Publicado no ESMO Open (2016)

Threat posed by unproven drugs in medical oncology

Por Pondé, Noam, Ades, Felipe, de Azambuja, Evandro
Publicado no ESMO Open (2016)

Cancer and the arts: why we need works by long-term survivors

Por Wagner, Wolfgang
Publicado no ESMO Open (2016)

Radiological staging in pregnant patients with cancer

Por Woitek, Ramona, Prayer, Daniela, Hojreh, Azadeh, Helbich, Thomas
Publicado no ESMO Open (2016)

Cancer and the arts: La Madonna dei Tumori, Ravenna, Italy

Por Wagner, Wolfgang
Publicado no ESMO Open (2016)

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life

Por Ciardiello, Fortunato, Tabernero, Josep
Publicado no ESMO Open (2016)

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

Por Sternberg, Cora N
Publicado no ESMO Open (2016)

Immune-related response criteria: light and shadows

Por Merlano, Marco, Occelli, Marcella, Garrone, Ornella
Publicado no ESMO Open (2016)

I-SPY 2: optimising cancer drug development in the 21st century

Por Bartsch, Rupert, de Azambuja, Evandro
Publicado no ESMO Open (2016)